2009

Regulatory Affairs

• Seasons Greetings, A. D'Emanuele
• [RegAffairs]Climatic zone, deepak jain
• [RegAffairs]Re: Climatic zone, Malcolm Ross
  • <Possible follow-up(s)>
  • [RegAffairs]Re: Climatic zone, Richard P Poska
  • [RegAffairs]Re: Climatic zone, Surender Kumar
  • [RegAffairs]Re: Climatic zone, PharmWeb
  • [RegAffairs]Re: Climatic zone, Brian MATTHEWS
  • [RegAffairs]Re: Climatic zone, Malcolm Ross
• [RegAffairs]BE report No of CRF, PAKHI RUSIA
• [RegAffairs]Cosmetovigilance Report, Luv Wadhwani
• [RegAffairs]Re: Cosmetovigilance Report, Muthiah Saravanan
  • <Possible follow-up(s)>
  • [RegAffairs]Re: Cosmetovigilance Report, Lassoff, Peter
• [RegAffairs]Regulatory guidelines, Brijesh Yadav
• [RegAffairs]DMF Annual Reports, Globepharm /Consulting
• [RegAffairs]RE: DMF Annual Reports, Ketan Agravat
• [RegAffairs]Excipient clarity, prasanna sagar
• [RegAffairs]Regulatory Affairs Certificate vs. Master of Sciencein RA, Luke
• [RegAffairs]Site registration in Japan, ivan piccoli
• [RegAffairs]Re: Site registration in Japan, Brian MATTHEWS
  • <Possible follow-up(s)>
  • [RegAffairs]Re: site registration in Japan, shakeel.salam
  • [RegAffairs]Re: Site registration in Japan, Surender Kamal
• [RegAffairs]Re: BE report no of CRF, shakeel
• [RegAffairs]USP versus in-house API specification, Kams
• [RegAffairs]RE: USP versus in-house API specification, Ketan Agravat
  • <Possible follow-up(s)>
  • [RegAffairs]Re: USP versus in-house API specification, Brian MATTHEWS
  • [RegAffairs]Re: USP versus in-house API specification, Malcolm Ross
• [RegAffairs]Biowaiver for Iron Containing Product, Surender Kamal
• [RegAffairs]Query on stability studies, Luv Wadhwani
• [RegAffairs]API % Assay Calculation in Commercial Batch, Anand G
• [RegAffairs]Re: Query on stability studies, Brian MATTHEWS
  • <Possible follow-up(s)>
  • [RegAffairs]Re: Query on stability studies, Malcolm Ross
  • [RegAffairs]Re: Query on stability studies, Surender Kamal
  • [RegAffairs]Re: Query on stability studies, aks
  • [RegAffairs]Re: Query on stability studies, ge guo
  • [RegAffairs]Re: Query on stability studies, Ranjith Gamage
• [RegAffairs]Re: API % Assay Calculation in Commercial Batch, Surender Kamal
  • <Possible follow-up(s)>
  • [RegAffairs]Re: API % Assay Calculation in Commercial Batch, Ranjith Gamage
• [RegAffairs]Query on Microbiological Testing of Non-Sterile Drugproducts; Oral Solid Dosage Forms, virgilio jun v villanueva
• [RegAffairs]Re: Query on Microbiological Testing of Non-SterileDrug products; Oral Solid Dosage Forms, Surender Kamal
  • <Possible follow-up(s)>
  • [RegAffairs]Re: Query on Microbiological Testing of Non-SterileDrug products; Oral Solid Dosage Forms, Meena Shah